Table 4.
Current exosomes engineering techniques for Af treatments.
| Exosomes engineering technologies | Pros | Cons |
|---|---|---|
| Encapsulate cargoes by sucrose gradient ultracentrifugation | Protect drugs from degradation, enhance drugs stability, bioavailability and effect | This protocol can only be used for hydrophobic drugs |
| Encapsulation cargoes through incubation, freeze-thaw cycles, sonication, and extrusion | Allows loading of both hydrophilic and hydrophobic drugs | Causes exosomal bilayer disruption |
| EV-imitating structure (liposomes) | Targeting, stable structure and contents | Physiochemical instability Can form unwanted degradants |
| Fusing cardiomyocyte-specific binding peptide to the exosomes (Cardiac homing peptide) | Enhance exosomes targeting | Displays only protein loading |
| Manipulation of the loading mechanism to selectively load cargoes into the exosomes (protein loading in exosomes based on integration of light sensitive reversible proteins interaction module) | Enhance exosomes targeting Controllable mechanism of loading |
Displays only protein loading |
| Transfection of a gene encoding exosome-targeting proteins into parent cells. | Enhance production efficiency, specific packaging, and delivery to target cells | Displays only protein loading |
| Heart patches and hydrogels | Making exosomes release more sustained with higher bioavailability; enhance exosomes effects with better target | The delivery approaches with enhanced retention is unsatisfactory |